Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -42.29%96.13M | -53.14%72.39M | 0.58%551.84M | -42.14%88.84M | 4.39%141.95M | 36.78%166.57M | 12.47%154.48M | 25.27%548.64M | 29.89%153.54M | 4.57%135.98M |
| Cost of revenue | -32.67%94.61M | -46.94%68.4M | 6.68%492.11M | -32.55%88.12M | 15.99%133.07M | 40.33%140.52M | 11.32%128.91M | 22.58%461.3M | 33.14%130.65M | -0.91%114.72M |
| Gross profit | -94.15%1.52M | -84.42%3.99M | -31.61%59.73M | -96.86%718K | -58.21%8.88M | 20.34%26.05M | 18.66%25.57M | 41.72%87.34M | 14.01%22.89M | 49.16%21.25M |
| Operating expense | -45.68%6.27M | -112.81%-1.29M | 85.65%49.15M | 82.29%14.94M | 165.75%14.11M | 140.40%11.55M | 22.95%10.04M | 78.11%26.48M | 90.27%8.2M | 57.18%5.31M |
| Selling and administrative expenses | 13.35%13.09M | 9.46%10.99M | 85.65%49.15M | 82.29%14.94M | 165.75%14.11M | 140.40%11.55M | 22.95%10.04M | 77.67%26.48M | 88.67%8.2M | 57.18%5.31M |
| -Selling and marketing expense | -0.38%794K | 177.36%1.47M | 278.16%2.75M | 144.72%602K | 301.95%824K | 764.17%797K | 33.50%530K | 94.93%728K | 194.70%246K | 120.58%205K |
| -General and administrative expense | 14.37%12.3M | 0.11%9.52M | 80.20%46.4M | 80.36%14.34M | 160.28%13.28M | 118.36%10.75M | 22.42%9.51M | 77.23%25.75M | 86.59%7.95M | 16.69%5.1M |
| Total other operating income | --6.82M | --12.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | -132.77%-4.75M | -66.07%5.27M | -82.61%10.58M | -196.82%-14.23M | -132.77%-5.23M | -13.91%14.5M | 16.05%15.53M | 30.16%60.87M | -6.82%14.69M | 46.67%15.95M |
| Net non-operating interest income (expenses) | -17.86%-2.16M | -25.03%-2.08M | -12.90%-8.94M | -57.34%-2.77M | -29.42%-2.67M | -4.85%-1.84M | 28.96%-1.67M | 12.07%-7.92M | 40.54%-1.76M | 6.10%-2.06M |
| Non-operating interest income | 13.45%675K | -3.38%829K | -8.72%2.8M | -14.22%700K | 1.90%643K | -53.04%595K | 145.85%858K | 3,061.90%3.06M | 3,180.80%816K | 2,529.17%631K |
| Non-operating interest expense | 16.78%2.84M | 15.37%2.91M | 6.87%11.73M | 34.65%3.47M | 22.98%3.31M | -19.45%2.43M | -6.31%2.52M | 24.94%10.98M | -3.57%2.57M | 21.30%2.69M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 126.73%135K | -88.71%473K | -882.99%-37.19M | -8,734.56%-26.33M | -1,183.47%-14.55M | -115.87%-505K | 701.34%4.19M | 269.30%4.75M | 96.61%-298K | -62.84%1.34M |
| Income before tax | -155.76%-6.78M | -79.73%3.66M | -161.61%-35.55M | -442.77%-43.32M | -247.43%-22.45M | -33.46%12.16M | 56.17%18.06M | 41.27%57.7M | 27.61%12.64M | 23.90%15.23M |
| Income tax | -421.93%-9.66M | -92.01%367K | -26.46%9.82M | -22.28%5.57M | -27,966.67%-3.34M | -3.57%3M | 49.98%4.59M | 82.90%13.36M | 638.91%7.17M | -99.37%12K |
| Net income | -68.54%2.88M | -75.53%3.29M | -202.32%-45.37M | -994.31%-48.89M | -225.56%-19.1M | -39.60%9.16M | 58.40%13.46M | 32.21%44.34M | -38.80%5.47M | 46.50%15.21M |
| Net income continuous operations | -68.54%2.88M | -75.53%3.29M | -202.32%-45.37M | -994.31%-48.89M | -225.56%-19.1M | -39.60%9.16M | 58.40%13.46M | 32.21%44.34M | -38.80%5.47M | 46.50%15.21M |
| Noncontrolling interests | -105.05%-23K | -337.29%-140K | 1,008.82%309K | -58.82%-54K | -151K | 455K | 59K | -34K | -34K | 0 |
| Net income attributable to the company | -66.63%2.9M | -74.38%3.43M | -202.94%-45.68M | -987.80%-48.84M | -224.57%-18.95M | -42.60%8.7M | 57.71%13.41M | 32.31%44.38M | -38.42%5.5M | 46.50%15.21M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -66.63%2.9M | -74.38%3.43M | -202.94%-45.68M | -987.80%-48.84M | -224.57%-18.95M | -42.60%8.7M | 57.71%13.41M | 32.31%44.38M | -38.42%5.5M | 46.50%15.21M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -67.05%0.0029 | -74.07%0.0035 | -192.74%-0.046 | -994.55%-0.0492 | -215.76%-0.0191 | -46.34%0.0088 | 26.17%0.0135 | 10.91%0.0496 | -53.82%0.0055 | 19.18%0.0165 |
| Diluted earnings per share | -67.05%0.0029 | -74.07%0.0035 | -192.74%-0.046 | -994.55%-0.0492 | -215.76%-0.0191 | -46.34%0.0088 | 26.17%0.0135 | 10.91%0.0496 | -53.82%0.0055 | 19.18%0.0165 |
| Dividend per share | 0 | 0 | 121.82%0.0122 | 0 | 21.82%0.0067 | 0 | 0.0055 | 0.0055 | 0 | 0.0055 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.